| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 01/19/2011 | CN101274086B Paste for purging heat and treating stranguria |
| 01/19/2011 | CN101209257B Medical use of baicalin and scutellarein derivatives |
| 01/19/2011 | CN101160290B 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 01/19/2011 | CN101133021B Crystallisation and purification of glycopyrronium bromide |
| 01/18/2011 | US7872133 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |
| 01/18/2011 | US7872112 comprising rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A),deoxyhypusine synthase (DHS) nucleic acids and polypeptides; human cytomegalovirus immediate-early promoter/enhancer |
| 01/18/2011 | US7872094 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD) |
| 01/18/2011 | US7871644 Mixture of drug, aminoacrylate polymer and acid |
| 01/18/2011 | CA2568590C Propane-1,3-dione derivative or salt thereof useful as gnrh receptor antagonist |
| 01/18/2011 | CA2503274C Basic medicine-containing preparation |
| 01/18/2011 | CA2475630C N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids |
| 01/18/2011 | CA2432148C Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 01/18/2011 | CA2432077C Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists |
| 01/18/2011 | CA2416874C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 01/18/2011 | CA2394843C A vaccine comprising lactobacillus strains for treating prostate inflammation and benign prostate hyperplasias |
| 01/18/2011 | CA2331460C Heterocyclic inhibitors of p38 |
| 01/18/2011 | CA2321881C Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications |
| 01/13/2011 | WO2011004733A1 Activity enhancer for oxidized protein hydrolase |
| 01/13/2011 | WO2011004148A1 Methods related to a mutation in complement factor h-related protein 5 in patients with glomerulonephritis |
| 01/13/2011 | WO2011004054A1 Use of carbonic anhydrase ii for producing a drug |
| 01/13/2011 | WO2011003342A1 Carboxylate compound and use thereof |
| 01/13/2011 | WO2011003129A1 Treatment of non-neuronal and non-myocardial cell, tissue and organ damage and associated pain with persistent sodium current blockers |
| 01/13/2011 | US20110009625 Novel compounds |
| 01/13/2011 | US20110009474 Sirtuin based methods and compositions for treating beta-catenin-related conditions |
| 01/13/2011 | US20110009455 5-Oxo-2,3,4,5-tetrahydro-benzo[b]oxepine-4-carboxylic acid amides and 2,3-Dihydro-benzo[b]oxepine-4-carboxylic acid amides for treatment and prevention of Diabetes Typ 1 and 2 |
| 01/13/2011 | US20110009452 Hydroxyalkanyl amides as modulators of chemokine receptor activity |
| 01/13/2011 | US20110009449 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/13/2011 | US20110009447 Substituted Benzoic Acid Amides and Use thereof for the Inhibition of Angiogenesis |
| 01/13/2011 | US20110009444 N-azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009437 Carboxamide-heteroaryl derivatives for the treatment of diabetes |
| 01/13/2011 | US20110009436 Novel therapeutic uses of adrenergic alpha-1 receptor antagonists |
| 01/13/2011 | US20110009409 Dual-acting pyrazole antihypertensive agents |
| 01/13/2011 | US20110009400 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009399 Organic compounds |
| 01/13/2011 | US20110009377 Azetidine derivatives, their preparation and their application in therapy |
| 01/13/2011 | US20110009367 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 01/13/2011 | US20110009364 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009312 Albumin Fusion Proteins |
| 01/13/2011 | US20110008357 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 01/13/2011 | US20110008338 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008337 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008336 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008324 Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof |
| 01/13/2011 | US20110008299 Treatment of pelvic floor disorders with an adipose-derived cell composition |
| 01/13/2011 | US20110008250 Treatment of Autoimmune Diseases |
| 01/12/2011 | EP2272959A1 BMP-11 compositions |
| 01/12/2011 | EP2272875A1 Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof |
| 01/12/2011 | EP2272854A1 Novel glycolipid and use thereof |
| 01/12/2011 | EP2272841A1 Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 01/12/2011 | EP2271624A1 Iminopyridine derivatives and use thereof |
| 01/12/2011 | EP2271405A2 Nip thiazole derivatives as inhibitors of 11-beta-hydorxysteroid dehydrogenase-1 |
| 01/12/2011 | EP2271334A2 Methods of treating fibrotic disorders |
| 01/12/2011 | EP1517907B1 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity |
| 01/12/2011 | EP1490357B1 Toluene solvate of darifenacin |
| 01/12/2011 | CN1939431B Medicine for treating prostatic accrementition |
| 01/12/2011 | CN101945855A Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 01/12/2011 | CN101945659A Adrenomedullin production enhancer |
| 01/12/2011 | CN101945657A Tablet having improved elution properties |
| 01/12/2011 | CN101940794A Csk binding protein inhibitor and application thereof |
| 01/12/2011 | CN101940789A Application of glucocorticoid to preparing medicament for treating tardive hemorrhagic cystitis |
| 01/12/2011 | CN101940779A Method for preparing medicinal composition for reinforcing spleen and kidney |
| 01/12/2011 | CN101940733A Traditional Chinese medicinal composition for curing nephritis diseases and preparation method thereof |
| 01/12/2011 | CN101940723A Chinese medicinal preparation for treating pyelonephritis |
| 01/12/2011 | CN101940718A Kidney-tonifying health care medicated wine |
| 01/12/2011 | CN101940716A Medicament for treating diabetic nephropathy |
| 01/12/2011 | CN101940713A Medicinal liquor for improving body immunity and preparation method thereof |
| 01/12/2011 | CN101940697A Medicament for treating prostatitis |
| 01/12/2011 | CN101940655A Detecting method of rehmannia-leaf total-glycoside capsule |
| 01/12/2011 | CN101940625A Preparation method and use of extract |
| 01/12/2011 | CN101940607A Effervescent composition including cranberry extract |
| 01/12/2011 | CN101940585A Composite using orientin-2'-O-beta-L-galactoside as main component and application thereof |
| 01/12/2011 | CN101518622B Traditional Chinese medicine for treating diabetes complicated with urinary infection |
| 01/12/2011 | CN101361885B Chinese traditional medicine composition for treating the prostatitis and preparation method thereof |
| 01/11/2011 | US7868002 Deazapurines and uses thereof |
| 01/11/2011 | CA2534088C 2,3-substituted pryidl compounds useful for treating pain |
| 01/11/2011 | CA2492138C N-phenyl-(2r,5s)dimethylpiperazine derivative |
| 01/11/2011 | CA2472149C New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments |
| 01/11/2011 | CA2451678C Azaindoles |
| 01/11/2011 | CA2430124C Lactam compounds and pharmaceutical use thereof |
| 01/11/2011 | CA2420592C Fused pyrrolocarbazoles against inflammation |
| 01/11/2011 | CA2387095C Compound with growth hormone releasing properties |
| 01/11/2011 | CA2286313C Novel ldl-receptor |
| 01/06/2011 | WO2011002184A2 Phosphoric acid ester of bicalutamide for treating prostate cancer |
| 01/06/2011 | WO2011002161A2 Transdermal composition comprising tolterodine |
| 01/06/2011 | WO2011002070A1 Pharmaceutical composition for treating iron overload disorders or diseases on which the reduction in iron concentration is effective, which comprises gdf7/bmp12 protein |
| 01/06/2011 | WO2011000104A1 Fluorinated derivatives of 3-hydroxypyridin-4-ones |
| 01/06/2011 | WO2010130773A3 Benzoxazolone derivatives as aldosterone symthase inhibitors |
| 01/06/2011 | US20110003864 Crystalline 1-(3-fluorophenyl)-5-methyl-2-(1h)pyridone, the preparation methods, compositions and applications thereof |
| 01/06/2011 | US20110003860 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 01/06/2011 | US20110003853 Metalloproteinase Inhibitors |
| 01/06/2011 | US20110003843 Novel compounds derived from indole and pharmaceutical compositions containing them |
| 01/06/2011 | US20110003824 Caspase Inhibitors and Uses Thereof |
| 01/06/2011 | US20110003812 Human Adam-10 Inhibitors |
| 01/06/2011 | US20110003750 Human 3 relaxin |
| 01/06/2011 | US20110003746 Protein variants |
| 01/06/2011 | US20110003388 processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient; making an enhanced, autologous fat graft comprising supplementing a first portion of extracted adipose tissue with an additive and a disaggregated population of adipose-derived cells |
| 01/06/2011 | US20110003360 Delta-6 desaturase and uses thereof |
| 01/06/2011 | US20110003351 Delta-5 desaturase and uses thereof |
| 01/06/2011 | US20110003020 Topical compositions for anti-aging and methods of using same |
| 01/06/2011 | US20110003000 Transvaginal Delivery of Drugs |